Stay informed with the latest company announcements, partnerships, and industry news
85 articles found
Caresyntax partners with Paragonix to expand real-world data for GUARDIAN registries – enhancing heart and lung transplant insights and clinical outcomes.
Read more
Caresyntax announced the appointment of Matt Krueger as Chief Executive Officer. Krueger succeeds company founders Dennis Kogan and Bjoern von Siemens.
Read more
Caresyntax and Incision announced a partnership poised to transform operating room performance. The collaboration will empower clinical staff, enhance efficiency, and significantly improve patient care.
Read more
Caresyntax and The Jacobs Institute, Inc. (JI) announced a strategic collaboration to elevate the use of Real-World Evidence (RWE) in product evaluation and patient outcome improvement.
Read more
Caresyntax and Pristine Surgical announced a partnership to enhance surgical intelligence for Pristine’s Summit and its Pristine Connect™ digital platform.
Read more
Caresyntax and Roivios have joined forces to accelerate the development of innovative medical technologies to improve patient outcomes in renal care.
Read more
Caresyntax and Qaelon Medical are launching a multi-phase partnership for the measurement and clinical management of surgical leaks — one of the most dreaded surgical complications
Read more
Caresyntax achieved top line 2024 organic revenue growth over 50%, with its technology and services platform used in over 4,000 ORs across the world. The company also completed a $180 million fundraise to fuel this explosive top and bottom-line growth.
Read moreCaresyntax is proud to announce its commitment to the EU AI Pact, reinforcing its dedication to advancing ethical and responsible artificial intelligence (AI) in healthcare.
Read more
Caresyntax has been awarded the prestigious 2024 German AI Prize. The awards were presented by Volker Wissing, Germany’s Federal Minister for Digitalization, in Berlin.
Read more
Caresyntax is pleased to announce raising a total commitment of $180 million through a series C extension and growth debt expansion round.
Read more
Caresyntax is excited to announce its recognition as one of the Fierce Healthcare's Fierce 15 of 2024, a prestigious acknowledgment of the most innovative healthcare companies across the United States.
Read more